Biohaven Earnings
NYSE: BHVNHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Next earnings date
Mon, Nov 9, 2026
Fiscal period
Sep/2026
EPS estimate
$-0.80
Biohaven earnings summary
Biohaven is scheduled to report Sep/2026 earnings on Nov 9, 2026, with analysts expecting EPS of $-0.80. In its most recent report on Aug 10, 2026 (Q2 2026), BHVN posted EPS of $-0.91. Across the last 16 reports, BHVN shares moved an average of 6.0% (in either direction) in the first trading session after results, rising 7 times and falling 9 times.
Summary generated from market data by MetaCap's automated system. Methodology
BHVN earnings history
| Report date | EPS est. | EPS actual | Surprise | Price reaction |
|---|---|---|---|---|
| Aug 10, 2026 | — | $-0.91 | — | -5.4% |
| May 4, 2026 | — | $-0.88 | — | -11.2% |
| Mar 2, 2026 | — | $-1.11 | — | -3.4% |
| Nov 10, 2025 | — | $-1.64 | — | +16.7% |
| Aug 11, 2025 | — | $-1.94 | — | -0.6% |
| May 12, 2025 | — | $-2.17 | — | -2.4% |
| Mar 3, 2025 | — | $-1.74 | — | -2.4% |
| Nov 12, 2024 | — | $-1.70 | — | +2.7% |
| Aug 9, 2024 | — | $-3.64 | — | -0.8% |
| May 9, 2024 | — | $-2.20 | — | +4.7% |
| Feb 29, 2024 | — | $-1.88 | — | +17.0% |
| Nov 14, 2023 | — | $-1.50 | — | +1.2% |
| Jul 31, 2023 | — | $-1.32 | — | +5.8% |
| May 12, 2023 | — | $-1.03 | — | +3.6% |
| Mar 23, 2023 | — | $-3.38 | — | -4.4% |
| Nov 9, 2022 | — | $-1.75 | — | -13.3% |
Surprise compares reported EPS with the consensus estimate. Price reaction is the close-to-close move in the first session after the report. Learn about the earnings surprise.